4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0000899243-23-019095
10% owner acquired 1,931,852 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| First Light Acquisition Group, LLC 10% owner | 2023-09-12 | Conversion | +1,931,852 | 1,931,852 | I | ||
| Derivatives | |||||||
| First Light Acquisition Group, LLC 10% owner | 2023-06-16 | Sale · Class B Common Stock, par value $0.0001 per share | −191,990 | 2,383,813 | I | ||
| First Light Acquisition Group, LLC 10% owner | 2023-09-12 | Sale · Class B Common Stock, par value $0.0001 per share | −99,388 | 2,284,425 | I | ||
| First Light Acquisition Group, LLC 10% owner | 2023-09-12 | Sale · Class B Common Stock, par value $0.0001 per share | −186,372 | 2,098,053 | I | ||
| First Light Acquisition Group, LLC 10% owner | 2023-09-12 | Other disposition · Class B Common Stock, par value $0.0001 per share | −166,201 | 1,931,852 | I | ||
| First Light Acquisition Group, LLC 10% owner | 2023-09-12 | Conversion · Class B Common Stock, par value $0.0001 per share | −1,931,852 | 0 | I | ||
Loading xslF345X05/doc4.xml…